---
$id: https://graph.org.ai/products/commodity/51273023
$type: Product
source: UNSPSC
code: "51273023"
title: "Remifentanil hydrochloride"
class: "51273000"
classTitle: "Anaesthetic piperidines"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Remifentanil hydrochloride

**UNSPSC Code**: 51273023
**Class**: [Anaesthetic piperidines](Anaesthetic piperidines.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist and opioid with the molecular formula C20H28N2O5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5V444H5WIC, chemically known as 4-carboxy-4-(n-phenylpropionamido)-1-piperidine propionic acid, dimethyl ester, monohydrochloride but more generally known as remifentanil hydrochloride, which bears US NIH Compound Identifier 60814. European Medicines Agency schedules Remifentanil hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04215MIG. Most nations, for tariff and trade purposes, schedule remifentanil hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, REMIFENTANIL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Remifentanil hydrochloride bears US NLM identifiers UMLS ID C0771827 and NCI Concept Code C47702. SMILES: CCC(=O)N(C1CCCCC1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC.CL.

